Abstract
There is growing evidence that 5-HT3 receptor blockade will benefit patients with fatigue. Further research is needed to determine the mechanism underlying this widespread clinically important symptom and therapies may be derived from targeting the 5-HT system.
| Original language | English |
|---|---|
| Pages (from-to) | 1056-1057 |
| Number of pages | 2 |
| Journal | Gut |
| Volume | 54 |
| DOIs | |
| Publication status | Published - 1 Aug 2005 |
Fingerprint
Dive into the research topics of '5-HT_3 receptor antagonists ameliorate fatigue: so much potential, so little knowledge'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver